コンテンツへスキップ
Merck
  • Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial.

Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial.

Acta obstetricia et gynecologica Scandinavica (2014-09-30)
Esther H M N Westen, Pascal R Kolk, Christine L van Velzen, Regine Unkels, Nicholaus S Mmuni, Alex D Hamisi, Ritha E Nakua, Anne L M Vlek, Heleen J van Beekhuizen
要旨

To investigate the efficacy of a single prophylactic dose of ampicillin combined with metronidazole to prevent postcesarean section infections compared with a multiple day regimen in low-resource settings. An evaluator-blinded randomized, controlled, noninferiority trial. Two rural hospitals in Tanzania. Of 181 enrolled eligible women with an indication for cesarean section, information on 176 was analyzed by intention-to-treat. The women were randomly assigned to either the intervention group who received a single dose of ampicillin and metronidazole, or to the control group who received a multiple-day regimen of ampicillin/amoxicillin and metronidazole. The primary outcome was maternal postcesarean infection. Secondary outcomes were severity of these infections, other maternal complications, and the duration of hospital stay. In the intervention group (n = 89), six women (6.7%) developed a wound infection compared with nine (10.3%) in the control group (n = 87) (difference 3.60; 95% CI -4.65 to 11.85) (p = 0.40). A single dose of prophylactic ampicillin and metronidazole is equally effective as a multiple-day regimen in preventing postcesarean wound infections in low-resource settings, therefore it can be considered as a good strategy in low-resource settings. The reduced quantity of prophylactic antibiotics will reduce costs without increasing the risk of maternal infection.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
アンピシリン ナトリウム塩, powder or crystals, BioReagent, suitable for cell culture
Sigma-Aldrich
アンピシリン, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
メトロニダゾール, BioXtra
Sigma-Aldrich
アンピシリン ナトリウム塩, BioXtra, suitable for cell culture
Sigma-Aldrich
アンピシリン ナトリウム塩
Sigma-Aldrich
アンピシリン 三水和物, 900-1050 μg/mg anhydrous basis (HPLC)
USP
アンピシリン, United States Pharmacopeia (USP) Reference Standard
Supelco
メトロニダゾール, analytical standard
Supelco
メトロニダゾール, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ampicillin, meets USP testing specifications
Supelco
アンピシリン, analytical standard
Supelco
アンピシリン 三水和物, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
アンピシリン ナトリウム塩, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
メトロニダゾール, SAJ first grade, ≥99.0%
Supelco
メトロニダゾール, VETRANAL®, analytical standard
アンピシリン, anhydrous, European Pharmacopoeia (EP) Reference Standard
Supelco
アンピシリン 三水和物, VETRANAL®, analytical standard
メトロニダゾール, European Pharmacopoeia (EP) Reference Standard
アンピシリン 三水和物, European Pharmacopoeia (EP) Reference Standard